Last reviewed · How we verify
Arm 1: IL13Ra2-specific CAR Tcm cells — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Arm 1: IL13Ra2-specific CAR Tcm cells (Arm 1: IL13Ra2-specific CAR Tcm cells) — City of Hope Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Arm 1: IL13Ra2-specific CAR Tcm cells TARGET | Arm 1: IL13Ra2-specific CAR Tcm cells | City of Hope Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Arm 1: IL13Ra2-specific CAR Tcm cells CI watch — RSS
- Arm 1: IL13Ra2-specific CAR Tcm cells CI watch — Atom
- Arm 1: IL13Ra2-specific CAR Tcm cells CI watch — JSON
- Arm 1: IL13Ra2-specific CAR Tcm cells alone — RSS
Cite this brief
Drug Landscape (2026). Arm 1: IL13Ra2-specific CAR Tcm cells — Competitive Intelligence Brief. https://druglandscape.com/ci/arm-1-il13ra2-specific-car-tcm-cells. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab